Follow the people · Insider
Marion McCourt
Marion McCourt files insider transactions with the SEC as an evp commercial of Regeneron Pharmaceuticals (REGN). We hold 2 disclosed purchases and sales filed since 4 February 2016, 2 of them in the last 90 days.
- Files forREGN
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure3 September 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 12 February 2018 — 3 September 2026EVP Commercial · Regeneron Pharmaceuticals (REGN)155 Form 4 lines · source: SEC Form 4
- Filed 25 January 2017 — 2 July 2018Director · Scynexis (SCYX)9 Form 4 lines · source: SEC Form 4
- Filed 29 March 2017 — 20 June 2017Director · CytomX Therapeutics (CTMX)2 Form 4 lines · source: SEC Form 4
- Filed 7 April 2017 — 7 April 2017Principal Operating Officer · Axovant Sciences (AXON)1 Form 4 line · source: SEC Form 4
- Filed 3 February 2016 — 28 September 2016Chief Operating Officer · Medivation (MDVN)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,215 shares of Regeneron PharmaceuticalsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 1,131 shares of Regeneron PharmaceuticalsSEC Form 43 September 2026Common Stock · traded 3 September 2026 · filed 3 September 2026
- had shares withheld for tax on 1,021 shares of Regeneron PharmaceuticalsSEC Form 411 December 2025Common Stock · traded 9 December 2025 · filed 11 December 2025
- was granted 12,210 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 49 December 2025Non-Qualified Stock Option (right to buy) · traded 5 December 2025 · filed 9 December 2025
- was granted 2,476 shares of Regeneron PharmaceuticalsSEC Form 49 December 2025Common Stock · traded 5 December 2025 · filed 9 December 2025
- had shares withheld for tax on 1,336 shares of Regeneron PharmaceuticalsSEC Form 49 December 2025Common Stock · traded 8 December 2025 · filed 9 December 2025
- had shares withheld for tax on 759 shares of Regeneron PharmaceuticalsSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- was granted 8,981 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 410 December 2024Non-Qualified Stock Option (right to buy) · traded 6 December 2024 · filed 10 December 2024
- was granted 2,332 shares of Regeneron PharmaceuticalsSEC Form 410 December 2024Common Stock · traded 6 December 2024 · filed 10 December 2024
- had shares withheld for tax on 274 shares of Regeneron PharmaceuticalsSEC Form 410 December 2024Common Stock · traded 9 December 2024 · filed 10 December 2024
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 November 2024Non-Qualified Stock Option (right to buy) · traded 1 November 2024 · filed 5 November 2024
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 October 2024Non-Qualified Stock Option (right to buy) · traded 1 October 2024 · filed 3 October 2024
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 September 2024Non-Qualified Stock Option (right to buy) · traded 3 September 2024 · filed 5 September 2024
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- exercised options over 1,137 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 August 2024Non-Qualified Stock Option (right to buy) · traded 1 August 2024 · filed 5 August 2024
- exercised options over 1,137 shares of Regeneron PharmaceuticalsSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- ▼ sold on the open market 1,137 shares of Regeneron PharmaceuticalsSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- exercised options over 1,137 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 July 2024Non-Qualified Stock Option (right to buy) · traded 1 July 2024 · filed 2 July 2024
- exercised options over 1,137 shares of Regeneron PharmaceuticalsSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 1,137 shares of Regeneron PharmaceuticalsSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- exercised options over 1,138 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 June 2024Non-Qualified Stock Option (right to buy) · traded 3 June 2024 · filed 5 June 2024
- exercised options over 1,138 shares of Regeneron PharmaceuticalsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 1,138 shares of Regeneron PharmaceuticalsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 250 shares of Regeneron PharmaceuticalsSEC Form 43 May 2024Common Stock · traded 1 May 2024 · filed 3 May 2024
- ▼ sold on the open market 250 shares of Regeneron PharmaceuticalsSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 358 shares of Regeneron PharmaceuticalsSEC Form 45 March 2024Common Stock · traded 1 March 2024 · filed 5 March 2024
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 46 February 2024Common Stock · traded 5 February 2024 · filed 6 February 2024
- ▼ sold on the open market 273 shares of Regeneron PharmaceuticalsSEC Form 42 February 2024Common Stock · traded 1 February 2024 · filed 2 February 2024
- ▼ sold on the open market 274 shares of Regeneron PharmaceuticalsSEC Form 44 January 2024Common Stock · traded 2 January 2024 · filed 4 January 2024
- had shares withheld for tax on 5,105 shares of Regeneron PharmaceuticalsSEC Form 414 December 2023Common Stock · traded 12 December 2023 · filed 14 December 2023
- was granted 7,649 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 412 December 2023Non-Qualified Stock Option (right to buy) · traded 8 December 2023 · filed 12 December 2023
- had shares withheld for tax on 852 shares of Regeneron PharmaceuticalsSEC Form 412 December 2023Common Stock · traded 8 December 2023 · filed 12 December 2023
- was granted 2,133 shares of Regeneron PharmaceuticalsSEC Form 412 December 2023Common Stock · traded 8 December 2023 · filed 12 December 2023
- ▼ sold on the open market 270 shares of Regeneron PharmaceuticalsSEC Form 412 December 2023Common Stock · traded 11 December 2023 · filed 12 December 2023
- had shares withheld for tax on 373 shares of Regeneron PharmaceuticalsSEC Form 412 December 2023Common Stock · traded 11 December 2023 · filed 12 December 2023
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 November 2023Non-Qualified Stock Option (right to buy) · traded 1 November 2023 · filed 2 November 2023
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 42 November 2023Common Stock · traded 1 November 2023 · filed 2 November 2023
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 42 November 2023Common Stock · traded 1 November 2023 · filed 2 November 2023
- exercised options over 1,038 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 October 2023Non-Qualified Stock Option (right to buy) · traded 2 October 2023 · filed 3 October 2023
- exercised options over 1,038 shares of Regeneron PharmaceuticalsSEC Form 43 October 2023Common Stock · traded 2 October 2023 · filed 3 October 2023
- ▼ sold on the open market 1,038 shares of Regeneron PharmaceuticalsSEC Form 43 October 2023Common Stock · traded 2 October 2023 · filed 3 October 2023
- ▼ sold on the open market 250 shares of Regeneron PharmaceuticalsSEC Form 46 September 2023Common Stock · traded 1 September 2023 · filed 6 September 2023
- ▼ sold on the open market 250 shares of Regeneron PharmaceuticalsSEC Form 43 August 2023Common Stock · traded 1 August 2023 · filed 3 August 2023
- ▼ sold on the open market 250 shares of Regeneron PharmaceuticalsSEC Form 46 July 2023Common Stock · traded 3 July 2023 · filed 6 July 2023
- ▼ sold on the open market 250 shares of Regeneron PharmaceuticalsSEC Form 42 June 2023Common Stock · traded 1 June 2023 · filed 2 June 2023
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 April 2023Non-Qualified Stock Option (right to buy) · traded 3 April 2023 · filed 5 April 2023
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 45 April 2023Common Stock · traded 3 April 2023 · filed 5 April 2023
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 45 April 2023Common Stock · traded 3 April 2023 · filed 5 April 2023
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 March 2023Non-Qualified Stock Option (right to buy) · traded 1 March 2023 · filed 3 March 2023
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 March 2023Common Stock · traded 1 March 2023 · filed 3 March 2023
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 March 2023Common Stock · traded 1 March 2023 · filed 3 March 2023
- had shares withheld for tax on 1,276 shares of Regeneron PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 12 February 2023 · filed 14 February 2023
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 48 February 2023Non-Qualified Stock Option (right to buy) · traded 7 February 2023 · filed 8 February 2023
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 48 February 2023Common Stock · traded 7 February 2023 · filed 8 February 2023
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 48 February 2023Common Stock · traded 7 February 2023 · filed 8 February 2023
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 February 2023Non-Qualified Stock Option (right to buy) · traded 1 February 2023 · filed 3 February 2023
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 February 2023Common Stock · traded 1 February 2023 · filed 3 February 2023
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 February 2023Common Stock · traded 1 February 2023 · filed 3 February 2023
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 January 2023Non-Qualified Stock Option (right to buy) · traded 3 January 2023 · filed 5 January 2023
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 45 January 2023Common Stock · traded 3 January 2023 · filed 5 January 2023
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 45 January 2023Common Stock · traded 3 January 2023 · filed 5 January 2023
- was granted 10,971 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 420 December 2022Non-Qualified Stock Option (right to buy) · traded 16 December 2022 · filed 20 December 2022
- was granted 2,973 shares of Regeneron PharmaceuticalsSEC Form 420 December 2022Common Stock · traded 16 December 2022 · filed 20 December 2022
- had shares withheld for tax on 274 shares of Regeneron PharmaceuticalsSEC Form 413 December 2022Common Stock · traded 9 December 2022 · filed 13 December 2022
- ▼ sold on the open market 264 shares of Regeneron PharmaceuticalsSEC Form 413 December 2022Common Stock · traded 12 December 2022 · filed 13 December 2022
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 December 2022Non-Qualified Stock Option (right to buy) · traded 1 December 2022 · filed 2 December 2022
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 December 2022Common Stock · traded 1 December 2022 · filed 2 December 2022
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 December 2022Common Stock · traded 1 December 2022 · filed 2 December 2022
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 47 November 2022Non-Qualified Stock Option (right to buy) · traded 4 November 2022 · filed 7 November 2022
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 47 November 2022Common Stock · traded 4 November 2022 · filed 7 November 2022
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 47 November 2022Common Stock · traded 4 November 2022 · filed 7 November 2022
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 November 2022Non-Qualified Stock Option (right to buy) · traded 1 November 2022 · filed 2 November 2022
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 November 2022Common Stock · traded 1 November 2022 · filed 2 November 2022
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 November 2022Common Stock · traded 1 November 2022 · filed 2 November 2022
- exercised options over 500 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 October 2022Non-Qualified Stock Option (right to buy) · traded 3 October 2022 · filed 5 October 2022
- exercised options over 600 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 October 2022Non-Qualified Stock Option (right to buy) · traded 3 October 2022 · filed 5 October 2022
- exercised options over 600 shares of Regeneron PharmaceuticalsSEC Form 45 October 2022Common Stock · traded 3 October 2022 · filed 5 October 2022
- ▼ sold on the open market 600 shares of Regeneron PharmaceuticalsSEC Form 45 October 2022Common Stock · traded 3 October 2022 · filed 5 October 2022
- exercised options over 500 shares of Regeneron PharmaceuticalsSEC Form 45 October 2022Common Stock · traded 3 October 2022 · filed 5 October 2022
- ▼ sold on the open market 500 shares of Regeneron PharmaceuticalsSEC Form 45 October 2022Common Stock · traded 3 October 2022 · filed 5 October 2022
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 September 2022Non-Qualified Stock Option (right to buy) · traded 1 September 2022 · filed 2 September 2022
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 September 2022Common Stock · traded 1 September 2022 · filed 2 September 2022
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 September 2022Common Stock · traded 1 September 2022 · filed 2 September 2022
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 August 2022Non-Qualified Stock Option (right to buy) · traded 1 August 2022 · filed 2 August 2022
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 August 2022Common Stock · traded 1 August 2022 · filed 2 August 2022
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 42 August 2022Common Stock · traded 1 August 2022 · filed 2 August 2022
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 July 2022Non-Qualified Stock Option (right to buy) · traded 1 July 2022 · filed 5 July 2022
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 45 July 2022Common Stock · traded 1 July 2022 · filed 5 July 2022
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 45 July 2022Common Stock · traded 1 July 2022 · filed 5 July 2022
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 June 2022Non-Qualified Stock Option (right to buy) · traded 1 June 2022 · filed 3 June 2022
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 June 2022Common Stock · traded 1 June 2022 · filed 3 June 2022
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 June 2022Common Stock · traded 1 June 2022 · filed 3 June 2022
- exercised options over 1,100 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 May 2022Non-Qualified Stock Option (right to buy) · traded 2 May 2022 · filed 3 May 2022
- exercised options over 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 May 2022Common Stock · traded 2 May 2022 · filed 3 May 2022
- ▼ sold on the open market 1,100 shares of Regeneron PharmaceuticalsSEC Form 43 May 2022Common Stock · traded 2 May 2022 · filed 3 May 2022
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 44 April 2022Non-Qualified Stock Option (right to buy) · traded 1 April 2022 · filed 4 April 2022
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 44 April 2022Common Stock · traded 1 April 2022 · filed 4 April 2022
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 44 April 2022Common Stock · traded 1 April 2022 · filed 4 April 2022
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 March 2022Non-Qualified Stock Option (right to buy) · traded 1 March 2022 · filed 3 March 2022
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 43 March 2022Common Stock · traded 1 March 2022 · filed 3 March 2022
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 43 March 2022Common Stock · traded 1 March 2022 · filed 3 March 2022
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 February 2022Non-Qualified Stock Option (right to buy) · traded 1 February 2022 · filed 2 February 2022
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 42 February 2022Common Stock · traded 1 February 2022 · filed 2 February 2022
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 42 February 2022Common Stock · traded 1 February 2022 · filed 2 February 2022
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 45 January 2022Non-Qualified Stock Option (right to buy) · traded 3 January 2022 · filed 5 January 2022
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 45 January 2022Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 45 January 2022Common Stock · traded 3 January 2022 · filed 5 January 2022
- had shares withheld for tax on 388 shares of Regeneron PharmaceuticalsSEC Form 414 December 2021Common Stock · traded 11 December 2021 · filed 14 December 2021
- ▼ sold on the open market 344 shares of Regeneron PharmaceuticalsSEC Form 414 December 2021Common Stock · traded 13 December 2021 · filed 14 December 2021
- was granted 14,253 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 410 December 2021Non-Qualified Stock Option (right to buy) · traded 8 December 2021 · filed 10 December 2021
- was granted 3,338 shares of Regeneron PharmaceuticalsSEC Form 410 December 2021Common Stock · traded 8 December 2021 · filed 10 December 2021
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 42 December 2021Non-Qualified Stock Option (right to buy) · traded 1 December 2021 · filed 2 December 2021
- exercised options over 1,000 shares of Regeneron PharmaceuticalsSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 1,000 shares of Regeneron PharmaceuticalsSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- exercised options over 1,000 shares of Regeneron Pharmaceuticals (a derivative holding)SEC Form 43 November 2021Non-Qualified Stock Option (right to buy) · traded 1 November 2021 · filed 3 November 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.